Once cardiac injury occurs, the number of mast cells increases significantly.[38] IL-4 secreted by mast cells may mediate immunomodulatory and pro-fibrotic effects, and reduced cardiac hypertrophy is usually accompanied by mast cell deficiency. The gene discussed is IL4; the disease is cardiac hypertrophy.